Replies to post #197751 on NorthWest Biotherapeutics Inc (NWBO)

[JTORENCE]

If she has that info and it is considered material info, she had better go public with it ASAP or the SEC will again be knocking on her door again.

[Doc logic]

Sojourner55,

Thanks to the sleuthing done on this board, the blinded 2018 Spring Refresh data could look so good based on the final enrolled patient cohort that preliminary deals could be lined up based on that with final payments based on final results from what the final commercial product will actually prove to do. Less confounded signalling can be making a big difference. Best wishes.